GlaxoSmithKline P.L.C., the world's second-biggest
drugmaker, begins a trial in Philadelphia next week in what...
Antidepressant Drug
GlaxoSmithKline P.L.C., the world's second-biggest drugmaker, begins a trial in Philadelphia next week in...
Sept. 15 (Bloomberg) -- An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked...
NEW YORK — Just a third of patients on long-term antidepressant drug
therapy report being...
